Federal Court of Appeal reserves decision on B.C. ostrich cull case
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
National Post
5 hours ago
- National Post
Bausch + Lomb Announces Publication of Phase 3 Data on LUMIFY® Preservative Free Redness Reliever Eye Drops
Article content Phase 3 data show Bausch + Lomb's LUMIFY Preservative Free eye drops are as safe and effective as the original LUMIFY in reducing ocular redness The multicenter study with 380 participants confirmed that LUMIFY Preservative Free eye drops are non-inferior in efficacy to the original LUMIFY and have a favorable safety profile, offering an effective preservative-free option for sensitive eyes LUMIFY delivers noticeable results in one minute, lasts up to eight hours and is the No. 1 doctor-recommended redness reliever brand; more info at Article content VAUGHAN, Ontario — Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced Ophthalmology and Therapy has published results from a phase 3 study which assessed the efficacy and safety of LUMIFY Preservative Free redness reliever eye drops compared to LUMIFY redness reliever eye drops for reducing ocular redness. Article content 'Since launching in 2018, LUMIFY has been the No. 1 doctor-recommended redness reliever brand, known for delivering noticeable results in one minute and lasting up to eight hours,' 1 said John Ferris, president, Consumer, Bausch + Lomb. 'This study demonstrates that our new LUMIFY Preservative Free eye drops reduce redness quickly and are just as safe and effective as the original LUMIFY, providing a needed option for patients with eye sensitivities.' Article content In the randomized, active-controlled, multicenter study, 380 participants with ocular redness received either LUMIFY Preservative Free or LUMIFY, administered as a single drop four times daily for four weeks. The primary objective was to demonstrate that LUMIFY Preservative Free is non-inferior to LUMIFY in reducing ocular redness. The primary efficacy endpoint was investigator-assessed ocular redness score at eight timepoints from five-minutes to 240-minutes after drop administration on day one. The secondary objective of the study was to compare the safety of LUMIFY Preservative Free and LUMIFY. Article content The study met its primary objective, confirming that LUMIFY Preservative Free is statistically non-inferior to LUMIFY in reducing ocular redness in adults. A day one analysis of all 11 time points (one minute to 480 minutes post-administration) further supported these findings; and additional secondary efficacy endpoint data from one minute, 360 minutes and 480 minutes post-administration demonstrated that LUMIFY Preservative Free performs similarly to LUMIFY. The overall safety profile of LUMIFY Preservative Free was favorable and comparable to LUMIFY, and the occurrence of ocular treatment-emergent adverse events was similar in both treatment groups. In this clinical trial, LUMIFY Preservative Free demonstrated to have a low incidence of side effects, like rebound redness and loss of efficacy over time, when used as directed. Article content 'The results show that LUMIFY Preservative Free is a well-tolerated alternative option for consumers with ocular redness who have sensitivities to preservatives or are at increased risk of ocular surface disease,' said Melissa Toyos, MD, and partner, Toyos Clinic, Nashville, TN. Article content About the LUMIFY Brand Article content The LUMIFY brand began in 2018 with the U.S. launch of LUMIFY redness reliever eye drops. Before LUMIFY, redness relievers relied on the same ingredients for decades and were associated with well-known side effects. LUMIFY and LUMIFY Preservative Free are the only over-the-counter redness relievers formulated with low-dose brimonidine tartrate 0.025% that selectively target eye redness and offer excellent results with a lower risk of rebound redness and loss of efficacy when used as directed. In 2023, Bausch + Lomb introduced LUMIFY EYE ILLUMINATIONS™, a line of specialty eye care products specifically developed for the sensitive area around the eyes. In June 2025, Bausch + Lomb launched LUMIFY Preservative Free eye drops in the U.S. For more information on the LUMIFY brand, visit Article content Bausch + Lomb is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from birth through every phase of life. Its comprehensive portfolio of approximately 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, Bausch + Lomb has a significant global research and development, manufacturing and commercial footprint with approximately 13,500 employees and a presence in approximately 100 countries. Bausch + Lomb is headquartered in Vaughan, Ontario, with corporate offices in Bridgewater, New Jersey. For more information, visit Article content Facebook Article content , Article content Instagram Article content , Article content LinkedIn Article content , Article content X Article content and Article content YouTube Article content . Article content References Article content ©2025 Bausch + Lomb. Article content Article content Article content Article content Article content Article content Contacts Article content Media Contact: Article content Article content Kristy Marks Article content Article content Article content
CTV News
5 hours ago
- CTV News
Happy days for fundraising campaign in New Tecumseth
Alliston and Angus McDonald's McHappy Day raised $12,500 for the Stevenson Memorial Hospital Foundation (SMHF). In addition, SMHF received an extra $14,000 during its Because of YOU relaunch event, further strengthening its partnership and commitment to hospital redevelopment efforts. Together, this funding brings the total contributions from MacKinnon Restaurants, that owns McDonald's in both Alliston and Angus, to an impressive $200,000 to the Stevenson Memorial Hospital Foundation. 'We're incredibly proud to be part of a community that values and supports our local hospital. Every dollar raised during events like McHappy Day makes a real difference—it helps us provide the best possible care for our family, neighbours, and loved ones,' said Rory MacKinnon, owner/operator of McDonald's in Alliston and Angus. The Because of You campaign is an effort to raise funds from the community to help build a future of Stevenson Memorial Hospital. This project will triple the size of the hospital, provide expanded emergency care and advanced diagnostic imaging, including Stevenson's first MRI suite. Community funds will also be put toward modern inpatient facilities, and specialized surgical services, all designed to meet the evolving healthcare needs of the growing community. 'We are deeply grateful to McDonald's in Alliston and Angus for their incredible generosity and unwavering support during McHappy Day. 'Their contributions play a crucial role in our overall efforts to advance the construction of Stevenson's new facility, which will significantly enhance healthcare services for our community,' said Frank Cerisano, CEO for SMHF. 'This support is significant as it helps us progress towards our $80 million Because of YOU campaign goal, helping to ensure that every patient continues to receive the quality care they deserve today and for generations to come.'
National Post
5 hours ago
- National Post
'They make you doubt your sanity.' Staff describe toxic workplace at top mental health hospital
Many staff inside the country's leading mental health institution say they are suffering their own trauma from a toxic workplace rife with discrimination and bullying. Article content Anonymous employee feedback from health-care providers at Toronto's Centre for Addiction and Mental Health (CAMH) include widespread staff complaints about a work culture they say left them with mental health challenges including anxiety, depression and even suicidality. Article content Article content Article content When they attempt to address their grievances, many say they were met with retaliation and a lack of accountability. Article content Article content Some staff blamed the workplace culture at CAMH for mental health challenges. 'They make you doubt your sanity,' one respondent wrote. Article content Some respondents explicitly noted a gap between the hospital's mental health mission and the psychological state of its employees. Article content 'It is ironic that an organization that provides mental health support is so disconnected from the mental health of its staff,' said one respondent. Article content Another wrote: 'The fact that the organization puts out statements about anti-racism that don't align with what we experience internally, it's a problem. They don't walk the talk internally.' Article content CAMH, hailed as a leading international mental health voice that provides training on staff mental health to major employers in Canada, said it has reviewed the criticisms by staff and taken active steps to address them. Article content 'I know this is what happens in workplaces — It is very different when you hear it from colleagues,' said CAMH equity director, Kwame McKenzie in an interview. 'It's very poignant. It's very raw. It makes you think of the urgency that you need to do something different.' Article content Article content The responses were gathered in 2021 and 2023 by an external consulting group and the hospital's equity office respectively, and were obtained by the Investigative Journalism Bureau through freedom of information legislation. Article content The internal reviews, which unfolded during COVID and the emergence of the Black Lives Matter movement, are only the latest attempts to understand longstanding issues at CAMH. Article content Following a 2019 internal survey that raised concerns of racism, hospital administrators decided additional indepth interviews were needed to better understand the experience of employees. In 2021 and 2023, a total of about 2,000 employees — nearly half the hospital's staff — took part in separate workplace reviews.
